337 related articles for article (PubMed ID: 11123999)
1. Synthesis, SARs, and pharmacological characterization of 2-amino-3 or 6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives as potent, selective, and orally active group II metabotropic glutamate receptor agonists.
Nakazato A; Kumagai T; Sakagami K; Yoshikawa R; Suzuki Y; Chaki S; Ito H; Taguchi T; Nakanishi S; Okuyama S
J Med Chem; 2000 Dec; 43(25):4893-909. PubMed ID: 11123999
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biology of the conformationally restricted ACPD analogue, 2-aminobicyclo[2.1.1]hexane-2,5-dicarboxylic acid-I, a potent mGluR agonist.
Kozikowski AP; Steensma D; Araldi GL; Tückmantel W; Wang S; Pshenichkin S; Surina E; Wroblewski JT
J Med Chem; 1998 May; 41(10):1641-50. PubMed ID: 9572889
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, in vitro pharmacology, and structure-activity relationships of 2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives as mGluR2 antagonists.
Yasuhara A; Sakagami K; Yoshikawa R; Chaki S; Nakamura M; Nakazato A
Bioorg Med Chem; 2006 May; 14(10):3405-20. PubMed ID: 16431115
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0] hexane-2,6-dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors.
Monn JA; Valli MJ; Massey SM; Hansen MM; Kress TJ; Wepsiec JP; Harkness AR; Grutsch JL; Wright RA; Johnson BG; Andis SL; Kingston A; Tomlinson R; Lewis R; Griffey KR; Tizzano JP; Schoepp DD
J Med Chem; 1999 Mar; 42(6):1027-40. PubMed ID: 10090786
[TBL] [Abstract][Full Text] [Related]
5. Antipsychotic action of selective group II metabotropic glutamate receptor agonist MGS0008 and MGS0028 on conditioned avoidance responses in the rat.
Takamori K; Hirota S; Chaki S; Tanaka M
Life Sci; 2003 Aug; 73(13):1721-8. PubMed ID: 12875903
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological and pharmacokinetic properties of a structurally novel, potent, and selective metabotropic glutamate 2/3 receptor agonist: in vitro characterization of agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]-hexane-4,6-dicarboxylic acid (LY404039).
Rorick-Kehn LM; Johnson BG; Burkey JL; Wright RA; Calligaro DO; Marek GJ; Nisenbaum ES; Catlow JT; Kingston AE; Giera DD; Herin MF; Monn JA; McKinzie DL; Schoepp DD
J Pharmacol Exp Ther; 2007 Apr; 321(1):308-17. PubMed ID: 17204749
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, in vitro pharmacology, structure-activity relationships, and pharmacokinetics of 3-alkoxy-2-amino-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives as potent and selective group II metabotropic glutamate receptor antagonists.
Nakazato A; Sakagami K; Yasuhara A; Ohta H; Yoshikawa R; Itoh M; Nakamura M; Chaki S
J Med Chem; 2004 Aug; 47(18):4570-87. PubMed ID: 15317467
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and metabotropic glutamate receptor activity of a 2-aminobicyclo[3.2.0]heptane-2,5-dicarboxylic acid, a molecule possessing an extended glutamate conformation.
Kozikowski AP; Araldi GL; Flippen-Anderson J; George C; Pshenichkin S; Surina E; Wroblewski J
Bioorg Med Chem Lett; 1998 Apr; 8(8):925-30. PubMed ID: 9871513
[TBL] [Abstract][Full Text] [Related]
9. Prodrugs of 3-(3,4-dichlorobenzyloxy)-2-amino-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (MGS0039): a potent and orally active group II mGluR antagonist with antidepressant-like potential.
Yasuhara A; Nakamura M; Sakagami K; Shimazaki T; Yoshikawa R; Chaki S; Ohta H; Nakazato A
Bioorg Med Chem; 2006 Jun; 14(12):4193-207. PubMed ID: 16487713
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): a potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic properties.
Monn JA; Valli MJ; Massey SM; Wright RA; Salhoff CR; Johnson BG; Howe T; Alt CA; Rhodes GA; Robey RL; Griffey KR; Tizzano JP; Kallman MJ; Helton DR; Schoepp DD
J Med Chem; 1997 Feb; 40(4):528-37. PubMed ID: 9046344
[TBL] [Abstract][Full Text] [Related]
11. MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity.
Chaki S; Yoshikawa R; Hirota S; Shimazaki T; Maeda M; Kawashima N; Yoshimizu T; Yasuhara A; Sakagami K; Okuyama S; Nakanishi S; Nakazato A
Neuropharmacology; 2004 Mar; 46(4):457-67. PubMed ID: 14975669
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo evidence for a lack of interaction with dopamine D2 receptors by the metabotropic glutamate 2/3 receptor agonists 1S,2S,5R,6S-2-aminobicyclo[3.1.0]hexane-2,6-bicaroxylate monohydrate (LY354740) and (-)-2-oxa-4-aminobicyclo[3.1.0] Hexane-4,6-dicarboxylic acid (LY379268).
Fell MJ; Perry KW; Falcone JF; Johnson BG; Barth VN; Rash KS; Lucaites VL; Threlkeld PG; Monn JA; McKinzie DL; Marek GJ; Svensson KA; Nelson DL
J Pharmacol Exp Ther; 2009 Dec; 331(3):1126-36. PubMed ID: 19755662
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and Pharmacological Characterization of C4
Monn JA; Henry SS; Massey SM; Clawson DK; Chen Q; Diseroad BA; Bhardwaj RM; Atwell S; Lu F; Wang J; Russell M; Heinz BA; Wang XS; Carter JH; Getman BG; Adragni K; Broad LM; Sanger HE; Ursu D; Catlow JT; Swanson S; Johnson BG; Shaw DB; McKinzie DL; Hao J
J Med Chem; 2018 Mar; 61(6):2303-2328. PubMed ID: 29350927
[TBL] [Abstract][Full Text] [Related]
14. Asymmetric synthesis and receptor pharmacology of the group II mGlu receptor ligand (1S,2R,3R,5R,6S)-2-amino-3-hydroxy-bicyclo[3.1.0]hexane-2,6-dicarboxylic acid-HYDIA.
Woltering TJ; Adam G; Huguenin P; Wichmann J; Kolczewski S; Gatti S; Bourson A; Kew JN; Richards G; Kemp JA; Mutel V; Knoflach F
ChemMedChem; 2008 Feb; 3(2):323-35. PubMed ID: 18058780
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and pharmacological characterization of 4-substituted-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylates: identification of new potent and selective metabotropic glutamate 2/3 receptor agonists.
Monn JA; Valli MJ; Massey SM; Hao J; Reinhard MR; Bures MG; Heinz BA; Wang X; Carter JH; Getman BG; Stephenson GA; Herin M; Catlow JT; Swanson S; Johnson BG; McKinzie DL; Henry SS
J Med Chem; 2013 Jun; 56(11):4442-55. PubMed ID: 23675965
[TBL] [Abstract][Full Text] [Related]
16. Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039).
Fell MJ; Svensson KA; Johnson BG; Schoepp DD
J Pharmacol Exp Ther; 2008 Jul; 326(1):209-17. PubMed ID: 18424625
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and anticonvulsant activity of novel bicyclic acidic amino acids.
Conti P; De Amici M; Joppolo Di Ventimiglia S; Stensbøl TB; Madsen U; Bräuner-Osborne H; Russo E; De Sarro G; Bruno G; De Micheli C
J Med Chem; 2003 Jul; 46(14):3102-8. PubMed ID: 12825948
[TBL] [Abstract][Full Text] [Related]
18. Investigating the role of mGluR2 versus mGluR3 in antipsychotic-like effects, sleep-wake architecture and network oscillatory activity using novel Han Wistar rats lacking mGluR2 expression.
Wood CM; Wafford KA; McCarthy AP; Hewes N; Shanks E; Lodge D; Robinson ESJ
Neuropharmacology; 2018 Sep; 140():246-259. PubMed ID: 30005976
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and Pharmacological Characterization of C4-(Thiotriazolyl)-substituted-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylates. Identification of (1R,2S,4R,5R,6R)-2-Amino-4-(1H-1,2,4-triazol-3-ylsulfanyl)bicyclo[3.1.0]hexane-2,6-dicarboxylic Acid (LY2812223), a Highly Potent, Functionally Selective mGlu2 Receptor Agonist.
Monn JA; Prieto L; Taboada L; Hao J; Reinhard MR; Henry SS; Beadle CD; Walton L; Man T; Rudyk H; Clark B; Tupper D; Baker SR; Lamas C; Montero C; Marcos A; Blanco J; Bures M; Clawson DK; Atwell S; Lu F; Wang J; Russell M; Heinz BA; Wang X; Carter JH; Getman BG; Catlow JT; Swanson S; Johnson BG; Shaw DB; McKinzie DL
J Med Chem; 2015 Sep; 58(18):7526-48. PubMed ID: 26313429
[TBL] [Abstract][Full Text] [Related]
20. 2-substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 2. Effects of aromatic substitution, pharmacological characterization, and bioavailability.
Ornstein PL; Bleisch TJ; Arnold MB; Kennedy JH; Wright RA; Johnson BG; Tizzano JP; Helton DR; Kallman MJ; Schoepp DD; Hérin M
J Med Chem; 1998 Jan; 41(3):358-78. PubMed ID: 9464367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
